Publication | Closed Access

Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial

OncologyPhase Ii TrialMetronomic TherapyClinical TrialsBronchial NeoplasmFirst-line TreatmentPharmacotherapyCancer TreatmentMedicineRadiation OncologyLung CancerRadiologyHealth Sciences